Prevention of Cytomegalovirus Disease in Recipients of Solid-Organ Transplants
Authors:
Open Access
- 15 February 2001
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 32 (4) , 596-603
Abstract
The introduction and combination of more-potent immunosuppressive regimens, and the increased transplantation of organs into more severely ill patienKeywords
This publication has 38 references indexed in Scilit:
- Prevention dof recurrent cytomegalovirus disease in renal and liver transplant recipients: effect of oral ganciclovirTransplant Infectious Disease, 2000
- Cytomegalovirus (CMV) DNA Load Predicts Relapsing CMV Infection after Solid Organ TransplantationThe Journal of Infectious Diseases, 2000
- High‐dose acyclovir prophylaxis reduces cytomegalovirus disease in liver transplant patientsTransplant Infectious Disease, 1999
- Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal TransplantationNew England Journal of Medicine, 1999
- Two grams daily of oral acyclovir reduces the incidence of cytomegalovirus disease in CMV-seropositive liver transplant recipientsTransplant International, 1997
- PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION IN LIVER TRANSPLANTATIONTransplantation, 1997
- Evaluation by polymerase chain reaction of cytomegalovirus reactivation in intensive care patients under mechanical ventilationIntensive Care Medicine, 1996
- A PROSPECTIVE RANDOMIZED STUDY OF ACYCLOVIR VERSUS GANCICLOVIR PLUS HUMAN IMMUNE GLOBULIN PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION AFTER SOLID ORGAN TRANSPLANTATION1,2Transplantation, 1994
- A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal AllograftsNew England Journal of Medicine, 1989
- Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant RecipientsNew England Journal of Medicine, 1987